(Q30936416)

English

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data

scientific article published on 31 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 September 2017

0 references

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data (English)

1 reference

Europe PubMed Central

16 September 2017

0 references

0 references

0 references

9

1 reference

Europe PubMed Central

16 September 2017

57

1 reference

Europe PubMed Central

16 September 2017

69

1 reference

Europe PubMed Central

16 September 2017

46

object named as

Corine Karema

1 reference

Europe PubMed Central

16 September 2017

Clarissa M Moreira

object named as

Clarissa Moreira

60

0 references

Georgina S Humphreys

object named as

Georgina S Humphreys

42

0 references

object named as

Prabin Dahal

19

0 references

Michel T Vaillant

object named as

Michel T Vaillant

102

0 references

object named as

Michel Cot

18

0 references

Philippe Deloron

object named as

Philippe Deloron

21

0 references

Christian Nsanzabana

object named as

Christian Nsanzabana

65

0 references

Roger Clément Kouly Tine

object named as

Roger C K Tine

100

0 references

object named as

Halidou Tinto

101

0 references

Todd D Swarthout

object named as

Todd D Swarthout

92

0 references

Clara Menéndez

object named as

Clara Menéndez

58

0 references

Nicholas John White

105

object named as

Nicholas J White

1 reference

Europe PubMed Central

16 September 2017

Ogobara K. Doumbo

26

object named as

Ogobara K Doumbo

1 reference

Europe PubMed Central

16 September 2017

25

object named as

Grant Dorsey

1 reference

Europe PubMed Central

16 September 2017

Peter Gottfried Kremsner

48

object named as

Peter G Kremsner

1 reference

Europe PubMed Central

16 September 2017

Umberto D'Alessandro

20

object named as

Umberto D'Alessandro

1 reference

Europe PubMed Central

16 September 2017

45

object named as

Moses R Kamya

1 reference

Europe PubMed Central

16 September 2017

103

object named as

Neena Valecha

1 reference

Europe PubMed Central

16 September 2017

Philip J Rosenthal

77

object named as

Philip J Rosenthal

1 reference

Europe PubMed Central

16 September 2017

Sarah G. Staedke

90

object named as

Sarah G Staedke

1 reference

Europe PubMed Central

16 September 2017

53

object named as

Bertrand Lell

1 reference

Europe PubMed Central

16 September 2017

Emiliana Tjitra

99

object named as

Emiliana Tjitra

1 reference

Europe PubMed Central

16 September 2017

95

object named as

Joel Tarning

1 reference

Europe PubMed Central

16 September 2017

Caterina I Fanello

object named as

Caterina I Fanello

29

0 references

Sodiomon B Sirima

85

object named as

Sodiomon B Sirima

1 reference

Europe PubMed Central

16 September 2017

Achille Massougbodji

55

object named as

Achille Massougbodji

1 reference

Europe PubMed Central

16 September 2017

Jean Louis Ndiaye

63

object named as

Jean-Louis Ndiaye

1 reference

Europe PubMed Central

16 September 2017

Abdoulaye A. Djimde

24

object named as

Abdoulaye A Djimde

1 reference

Europe PubMed Central

16 September 2017

68

object named as

Piero Olliaro

1 reference

Europe PubMed Central

16 September 2017

107

object named as

Issaka Zongo

1 reference

Europe PubMed Central

16 September 2017

Jean-Bosco Ouedraogo

70

object named as

Jean-Bosco Ouédraogo

1 reference

Europe PubMed Central

16 September 2017

Kasia Stepniewska

91

object named as

Kasia Stepniewska

1 reference

Europe PubMed Central

16 September 2017

Anders Björkman

11

object named as

Anders Björkman

1 reference

Europe PubMed Central

16 September 2017

89

object named as

Doudou Sow

1 reference

Europe PubMed Central

16 September 2017

22

object named as

Meghna Desai

1 reference

Europe PubMed Central

16 September 2017

Andreas Mårtensson

54

object named as

Andreas Mårtensson

1 reference

Europe PubMed Central

16 September 2017

Jean-Paul Guthmann

38

object named as

Jean-Paul Guthmann

1 reference

Europe PubMed Central

16 September 2017

31

object named as

Babacar Faye

1 reference

Europe PubMed Central

16 September 2017

33

object named as

Oumar Gaye

1 reference

Europe PubMed Central

16 September 2017

93

object named as

Khadime Sylla

1 reference

Europe PubMed Central

16 September 2017

Albert Same-Ekobo

79

object named as

Albert Same-Ekobo

1 reference

Europe PubMed Central

16 September 2017

Philippe Brasseur

15

object named as

Philippe Brasseur

1 reference

Europe PubMed Central

16 September 2017

Valérie Lameyre

50

object named as

Valérie Lameyre

1 reference

Europe PubMed Central

16 September 2017

Carolyn Nabasumba

61

object named as

Carolyn Nabasumba

1 reference

Europe PubMed Central

16 September 2017

Michael Nambozi

62

object named as

Michael Nambozi

1 reference

Europe PubMed Central

16 September 2017

74

object named as

Patrice Piola

1 reference

Europe PubMed Central

16 September 2017

Elizabeth A Ashley

5

object named as

Elizabeth A Ashley

1 reference

Europe PubMed Central

16 September 2017

75

object named as

Ric N Price

1 reference

Europe PubMed Central

16 September 2017

44

object named as

Elizabeth Juma

1 reference

Europe PubMed Central

16 September 2017

Francesco Checchi

17

object named as

Francesco Checchi

1 reference

Europe PubMed Central

16 September 2017

Jean François Faucher

30

object named as

Jean-François Faucher

1 reference

Europe PubMed Central

16 September 2017

39

object named as

Sally Hamour

1 reference

Europe PubMed Central

16 September 2017

Bernhards Ogutu

67

object named as

Bernhards R Ogutu

1 reference

Europe PubMed Central

16 September 2017

80

object named as

Birgit Schramm

1 reference

Europe PubMed Central

16 September 2017

Carol Hopkins Sibley

83

object named as

Carol Hopkins Sibley

1 reference

Europe PubMed Central

16 September 2017

Anyirékun Fabrice Somé

88

object named as

Fabrice A Somé

1 reference

Europe PubMed Central

16 September 2017

98

object named as

Julie I Thwing

1 reference

Europe PubMed Central

16 September 2017

Martin Madu Meremikwu

59

object named as

Martin Meremikwu

1 reference

Europe PubMed Central

16 September 2017

Karen I. Barnes

8

object named as

Karen I Barnes

1 reference

Europe PubMed Central

16 September 2017

52

object named as

Sue J Lee

1 reference

Europe PubMed Central

16 September 2017

2

object named as

Martin A Adjuik

1 reference

Europe PubMed Central

16 September 2017

Loretxu Pinoges

73

object named as

Loretxu Pinoges

1 reference

Europe PubMed Central

16 September 2017

Steffen Borrmann

14

object named as

Steffen Borrmann

1 reference

Europe PubMed Central

16 September 2017

Frederic Nikiema

64

object named as

Frederic Nikiema

1 reference

Europe PubMed Central

16 September 2017

Elisabeth Baudin

10

object named as

Elisabeth Baudin

1 reference

Europe PubMed Central

16 September 2017

author name string

WorldWide Antimalarial Resistance Network (WWARN) AS-AQ Study Group

1

1 reference

Europe PubMed Central

16 September 2017

Richard Allan

3

1 reference

Europe PubMed Central

16 September 2017

Anupkumar R Anvikar

4

1 reference

Europe PubMed Central

16 September 2017

Mamadou S Ba

6

1 reference

Europe PubMed Central

16 September 2017

Hubert Barennes

7

1 reference

Europe PubMed Central

16 September 2017

François Bompart

12

1 reference

Europe PubMed Central

16 September 2017

Maryline Bonnet

13

1 reference

Europe PubMed Central

16 September 2017

Hasifa Bukirwa

16

1 reference

Europe PubMed Central

16 September 2017

Graciela Diap

23

1 reference

Europe PubMed Central

16 September 2017

Emmanuelle Espié

27

1 reference

Europe PubMed Central

16 September 2017

Jean-Francois Etard

28

1 reference

Europe PubMed Central

16 September 2017

Raquel González

35

1 reference

Europe PubMed Central

16 September 2017

Francesco Grandesso

36

1 reference

Europe PubMed Central

16 September 2017

Armedy Ronny Hasugian

40

1 reference

Europe PubMed Central

16 September 2017

Vincent Jullien

43

1 reference

Europe PubMed Central

16 September 2017

Jean R Kiechel

47

1 reference

Europe PubMed Central

16 September 2017

Laminou M Ibrahim

51

1 reference

Europe PubMed Central

16 September 2017

Hervé Menan

56

1 reference

Europe PubMed Central

16 September 2017

Louis K Penali

71

1 reference

Europe PubMed Central

16 September 2017

Mbaye Pene

72

1 reference

Europe PubMed Central

16 September 2017

Claude Emile Rwagacondo

78

1 reference

Europe PubMed Central

16 September 2017

Amadou Seck

81

1 reference

Europe PubMed Central

16 September 2017

Bhawna Sharma

82

1 reference

Europe PubMed Central

16 September 2017

Véronique Sinou

84

1 reference

Europe PubMed Central

16 September 2017

Jeffery J Smith

86

1 reference

Europe PubMed Central

16 September 2017

Frank Smithuis

87

1 reference

Europe PubMed Central

16 September 2017

Ambrose O Talisuna

94

1 reference

Europe PubMed Central

16 September 2017

Walter R J Taylor

96

1 reference

Europe PubMed Central

16 September 2017

Emmanuel A Temu

97

1 reference

Europe PubMed Central

16 September 2017

Ingrid Van den Broek

104

1 reference

Europe PubMed Central

16 September 2017

Adoke Yeka

106

1 reference

Europe PubMed Central

16 September 2017

language of work or name

0 references

publication date

31 March 2015

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

13

1 reference

Europe PubMed Central

16 September 2017

66

1 reference

Europe PubMed Central

16 September 2017

copyright license

Creative Commons Attribution 4.0 International

31 March 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/s12916-015-0301-z

0 references

The effect of dose on the antimalarial efficacy of artemether-lumefantrine: A systematic review and pooled analysis of individual patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

The practice and clinical implications of tablet splitting in international health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

The interplay between drug resistance and fitness in malaria parasites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized [...]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Se

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

PfCRT and its role in antimalarial drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

A new world malaria map: Plasmodium falciparum endemicity in 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Pharmacokinetics and pharmacodynamics of a new ACT formulation: Artesunate/Amodiaquine (TRIMALACT) following oral administration in African malaria patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artemisinin-based combination therapy for treating uncomplicated malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

The role of anti-malarial drugs in eliminating malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Modelling clustered survival data from multicentre clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern S

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

The occurrence of lung cancer in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Antimalarial drug resistance and combination chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

21 June 2018

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Dosing accuracy of artesunate and amodiaquine as treatment for falciparum malaria in Casamance, Senegal.

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria.

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Seasonal variation in hyperparasitaemia and gametocyte carriage in patients with Plasmodium falciparum malaria on the Thai-Burmese border.

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam

1 reference

https://api.crossref.org/works/10.1186%2FS12916-015-0301-Z

21 January 2018

Short report: polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

25 November 2018

High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4411752

25 November 2018

Identifiers

10.1186/S12916-015-0301-Z

1 reference

Europe PubMed Central

16 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30936416&oldid=2118240095"